Literature DB >> 16460540

Evolving trends in infective endocarditis.

E E Hill1, P Herijgers, M-C Herregods, W E Peetermans.   

Abstract

Infective endocarditis is a microbial infection of the endocardial surface and, despite improvements in diagnostic accuracy, medical therapy and surgical techniques, mortality remains high. This review focuses on changes in epidemiology, microbiology and diagnosis, as well as changes in medical and surgical management of infective endocarditis affecting native and prosthetic valves in adults, that have evolved during the past two decades. Significant changes have included an increasing involvement of prosthetic valves and nosocomially-acquired disease, an increased involvement of staphylococci as the causative agents, and a recognition that elderly individuals with degenerative valvular disease are the most vulnerable population. Topics still requiring study include whether and when valve replacement should be performed, and how to predict perivalvular complications or embolisation based on echocardiography findings. Optimisation of antimicrobial treatment schemes (choice of the antibiotic, dose and duration) also requires further investigation.

Entities:  

Mesh:

Year:  2006        PMID: 16460540     DOI: 10.1111/j.1469-0691.2005.01289.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  25 in total

1.  Value of PCR in surgically treated patients with staphylococcal infective endocarditis: a 4-year retrospective study.

Authors:  B Zaloudíková; E Němcová; J Pol; Z Sorm; S Wurmová; K Novotná; M Vaněrková; V Holá; F Růžička; L Dušek; P Němec; T Freiberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

2.  The collagen-binding protein Cnm is required for Streptococcus mutans adherence to and intracellular invasion of human coronary artery endothelial cells.

Authors:  Jacqueline Abranches; James H Miller; Alaina R Martinez; Patricia J Simpson-Haidaris; Robert A Burne; José A Lemos
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

3.  Cardiac complications of infective endocarditis.

Authors:  John R Ebright
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

4.  Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA.

Authors:  Andrew M Edwards; Jennifer R Potts; Elisabet Josefsson; Ruth C Massey
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

5.  Surgical treatment of active infective endocarditis: A single center experience.

Authors:  Fahad Aziz; Sujatha Doddi; Sudheer Penupolu; Simanta Dutta; Anshu Alok
Journal:  J Thorac Dis       Date:  2010-09       Impact factor: 2.895

Review 6.  Coagulase-negative staphylococci.

Authors:  Karsten Becker; Christine Heilmann; Georg Peters
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

7.  Evidence for subpopulations of Listeria monocytogenes with enhanced invasion of cardiac cells.

Authors:  Francis Alonzo; Linda D Bobo; Daniel J Skiest; Nancy E Freitag
Journal:  J Med Microbiol       Date:  2011-01-25       Impact factor: 2.472

8.  Getting to the heart of rectal bleeding: subacute bacterial endocarditis presenting as anaemia and a GI bleed.

Authors:  Whitney Cesari; Christy Stewart; Mukta Panda
Journal:  BMJ Case Rep       Date:  2011-12-01

9.  Paradoxical Embolism in a Patient with Aortic Valve Endocarditis: A Case Report.

Authors:  Eduardo L Santos; Andre D Lima; Luca Dompieri; Arthur C Holanda; Maria A Aquino; Renato D Lopes
Journal:  Cureus       Date:  2018-03-10

10.  A randomised clinical trial of comprehensive cardiac rehabilitation versus usual care for patients treated for infective endocarditis--the CopenHeartIE trial protocol.

Authors:  Trine Bernholdt Rasmussen; Ann-Dorthe Zwisler; Kirstine Lærum Sibilitz; Signe Stelling Risom; Henning Bundgaard; Christian Gluud; Philip Moons; Per Winkel; Lau Caspar Thygesen; Jane Lindschou Hansen; Tone Merete Norekvål; Selina Kikkenborg Berg
Journal:  BMJ Open       Date:  2012-11-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.